Status:
COMPLETED
Use of Conversation and Acoustic Signals in Measuring Depression Severity
Lead Sponsor:
Boston Medical Center
Conditions:
Depression
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to test a new monitoring technology that uses the sound of a depressed person's speech to assess the severity of depression symptoms. The Vocal Social Signals Platform (VS...
Detailed Description
We will conduct a 24-month study that will include the test-retest reliability, criterion validity and sensitivity to change measurements of a novel monitoring technology that might provide an objecti...
Eligibility Criteria
Inclusion
- Be \> 18 years of age.
- Speak, understand and read conversational English.
- A clinical diagnosis of Major Depressive Disorder in the past 2 weeks.
Exclusion
- Not having access to a telephone at home or on the person (cell phone) or at work.
- Planning to leave Boston during the study period.
- Having a long history of smoking, which is defined as 1 pack per day for 10 years or more.
- Meeting the criteria for alcohol abuse.
- Having one of the following mental illnesses based on attached instruments: Social Anxiety, Bipolar Disorder (BD) or Borderline Personality Disorder (BPD).
- Having a life threatening and/or chronic health condition such as organic brain disease, e.g., Alzheimers' Disease and other dementias, cancer, HIV or other autoimmune diseases, diabetes, heart disease, renal failure, etc.
- Having a physical condition, such as one of the following, that could affect the acoustic characteristics of speech or a condition that can alter vocal production by affecting the mouth, larynx, trachea, lungs, thorax, nose, nasal passages and sinuses, ears and hearing:
- Neurological events or diseases such as stroke, ALS, brain injury, brain tumors, Parkinson's disease, Huntington's disease and multiple sclerosis
- Chronic allergic conditions such as allergic rhinitis
- Upper or lower respiratory track infections such as sinusitis
- GERD (acid reflux)
- Anatomic abnormalities such as deviated nasal septum
- Speech impairment, as determined by the research staff
- Any other permanent, chronic or intermittent conditions that affect the quality of speech
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT00831935
Start Date
January 1 2009
End Date
June 1 2011
Last Update
April 8 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118
2
Boston University Medical Campus
Boston, Massachusetts, United States, 02118